These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2654522)

  • 1. Hetrazepines as antagonists of platelet activating factor.
    Weber KH; Heuer HO
    Med Res Rev; 1989; 9(2):181-218. PubMed ID: 2654522
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationships and effects of platelet-activating factor antagonists in the hetrazepine series.
    Weber KH; Heuer H
    Int Arch Allergy Appl Immunol; 1989; 88(1-2):82-7. PubMed ID: 2540098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hetrazepine PAF antagonists.
    Ikegami K; Meade CJ; Heuer HO; Birke F
    J Lipid Mediat; 1992; 5(2):177-82. PubMed ID: 1326346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.
    Korth R; Hirafuji M; Keraly CL; Delautier D; Bidault J; Benveniste J
    Br J Pharmacol; 1989 Oct; 98(2):653-61. PubMed ID: 2555017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor antagonists in experimental shock.
    Muacevic G; Heuer HO
    Arzneimittelforschung; 1992 Aug; 42(8):1001-4. PubMed ID: 1418068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of WEB 2086 and WEB 2170 as platelet-activating factor antagonists.
    Casals-Stenzel J; Heuer HO
    Methods Enzymol; 1990; 187():455-65. PubMed ID: 2233357
    [No Abstract]   [Full Text] [Related]  

  • 7. [Platelet-activating factor (PAF) antagonists].
    Terasawa M
    Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with platelet-activating factor antagonists. Past, present, and near future.
    Guinot P
    Clin Rev Allergy; 1994; 12(4):397-417. PubMed ID: 7743464
    [No Abstract]   [Full Text] [Related]  

  • 10. From ginkgolides to N-substituted piperidino-thieno diazepines, a new series of highly potent dual antagonists.
    Braquet P; Laurent JP; Rolland A; Martin C; Pommier J; Hosford D; Esanu A
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():929-37. PubMed ID: 1825436
    [No Abstract]   [Full Text] [Related]  

  • 11. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
    Takatani M; Maezaki N; Imura Y; Terashita Z; Nishikawa K; Tsushima S
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():943-6. PubMed ID: 1825438
    [No Abstract]   [Full Text] [Related]  

  • 12. Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2.
    Walser A; Flynn T; Mason C; Crowley H; Maresca C; O'Donnell M
    J Med Chem; 1991 Apr; 34(4):1440-6. PubMed ID: 2016721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF antagonistic activity of some thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines.
    Tahara T; Mikashima H; Terasawa M; Maruyama Y
    Chem Pharm Bull (Tokyo); 1987 May; 35(5):2119-21. PubMed ID: 3664818
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of locally applied WEB 2086, a platelet-activating factor antagonist, on inflammatory skin conditions in mice.
    Kemény L; Trach V; Dobozy A
    Arch Dermatol Res; 1996 Jul; 288(8):492-4. PubMed ID: 8844132
    [No Abstract]   [Full Text] [Related]  

  • 15. The thieno-triazolodiazepine WEB 2086 inhibits platelet aggregation and ATP release from porcine platelets induced by platelet activating factor (PAF).
    Griffin KJ; Levy JV
    Thromb Res; 1988 Jul; 51(2):219-23. PubMed ID: 3187959
    [No Abstract]   [Full Text] [Related]  

  • 16. New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.
    Braquet P; Esanu A
    Agents Actions; 1991 Jan; 32(1-2):34-6. PubMed ID: 2058466
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet activating factor antagonists do not alter normal cerebral blood flow or cerebral oxygen consumption.
    Kochanek PM; Melick JA; Schoettle RJ; Magargee MJ; Evans RW; Nemoto EM
    Adv Exp Med Biol; 1990; 277():345-51. PubMed ID: 2096640
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO
    Lipids; 1991 Dec; 26(12):1369-73. PubMed ID: 1819735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity studies on triazolothienodiazepine derivatives as platelet-activating factor antagonists.
    Miyazawa S; Okano K; Shimomura N; Clark RS; Kawahara T; Asano O; Yoshimura H; Miyamoto M; Sakuma Y; Muramoto K
    Chem Pharm Bull (Tokyo); 1991 Dec; 39(12):3215-20. PubMed ID: 1814614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI; Muzia GI
    Vestn Akad Med Nauk SSSR; 1991; (10):13-7. PubMed ID: 1801455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.